Keywords: GLP-1, GIP, pharmacokinetics, drugdrug interactions, physiologically based pharmacokinetic model Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide hormone-derived analogs classified as incretin mimetic drugs (Figure 1)
Follow-up metabolic labs at 4-6 weeks, periodic kidney function checks, and open communication about side effects allow your provider to adjust dosing, pause treatment, or explore alternatives if needed
doi:10.1097/GME.0000000000002310 Centers for Disease Control
For someone targeting modest weight loss, this dual actionreduced hunger plus prolonged satietycreates a sustainable calorie deficit without the yo-yo cycles common to restrictive dieting
It exerts biological functions such as antioxidant and metabolic regulation through selenoproteins, which are key biomolecules